The physiological period length of the human circadian clock in vivo is directly proportional to period in human fibroblasts. by Pagani, L et al.
The Physiological Period Length of the Human Circadian
Clock In Vivo Is Directly Proportional to Period in Human
Fibroblasts
Lucia Pagani1., Ekaterina A. Semenova2., ErmannoMoriggi3, Victoria L. Revell4, Lisa M. Hack4, StevenW.
Lockley5, Josephine Arendt4, Debra J. Skene4, Fides Meier1, Jan Izakovic6, Anna Wirz-Justice7, Christian
Cajochen7, Oksana J. Sergeeva2, Sergei V. Cheresiz8, Konstantin V. Danilenko2, Anne Eckert1*, Steven A.
Brown3*
1Neurobiology Laboratory for Brain Aging and Mental Health, Psychiatric University Clinics Basel, Basel, Switzerland, 2 Institute of Internal Medicine of the Siberian Branch
of the Russian Academy of Medical Sciences, Novosibirsk, Russia, 3Department of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland, 4Centre for
Chronobiology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom, 5Circadian Physiology Program, Division of Sleep Medicine,
Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, 6Department of Dermatology, University Hospital Basel, Basel,
Switzerland, 7Centre for Chronobiology, Psychiatric University Clinics Basel, Basel, Switzerland, 8 Institute of Cytology and Genetics of the Siberian Branch of the Russian
Academy of Sciences, Novosibirsk, Russia
Abstract
Background: Diurnal behavior in humans is governed by the period length of a circadian clock in the suprachiasmatic nuclei
of the brain hypothalamus. Nevertheless, the cell-intrinsic mechanism of this clock is present in most cells of the body. We
have shown previously that for individuals of extreme chronotype (‘‘larks’’ and ‘‘owls’’), clock properties measured in human
fibroblasts correlated with extreme diurnal behavior.
Methodology/Principal Findings: In this study, we have measured circadian period in human primary fibroblasts taken
from normal individuals and, for the first time, compared it directly with physiological period measured in vivo in the same
subjects. Human physiological period length was estimated via the secretion pattern of the hormone melatonin in two
different groups of sighted subjects and one group of totally blind subjects, each using different methods. Fibroblast period
length was measured via cyclical expression of a lentivirally delivered circadian reporter. Within each group, a positive linear
correlation was observed between circadian period length in physiology and in fibroblast gene expression. Interestingly,
although blind individuals showed on average the same fibroblast clock properties as sighted ones, their physiological
periods were significantly longer.
Conclusions/Significance: We conclude that the period of human circadian behaviour is mostly driven by cellular clock
properties in normal individuals and can be approximated by measurement in peripheral cells such as fibroblasts. Based
upon differences among sighted and blind subjects, we also speculate that period can be modified by prolonged unusual
conditions such as the total light deprivation of blindness.
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Introduction
Nearly all aspects of human daily behavior and physiology are
governed by a master clock in the suprachiasmatic nuclei (SCN) of
the hypothalamus. This intrinsic oscillator not only governs sleep
and wake timing, but also rhythms of temperature, the hormones
melatonin and cortisol, mood and cognitive acuity, cardiac,
respiratory, and renal function, and most aspects of digestion
and detoxification [1]. These rhythms are entrained to 24 hours
by the environmental light-dark cycle primarily via a subset of
photosensitive retinal ganglion cells that project directly to the
SCN [2]. Using multiple hormonal and neuronal signals, the SCN
‘‘master’’ clock in turn entrains peripheral clocks of similar
molecular mechanism present in most cells of the body [3].
In humans and other organisms, the timing of 24-hour behavior
is governed by the period length of the circadian oscillator. This
period is approximately, but not exactly, 24 hours long (‘‘circa
diem’’), and has a reported population range of 23.47–24.64 in
laboratory conditions [4–11] Short periods lead to behavior
occurring at an earlier clock time in some individuals (so-called
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‘‘larks’’), and long periods to later timing of behavior in others
(‘‘owls’’) [9,12–14], at least in young adults. Mutations in clock
genes affect period length, and can lead to circadian rhythm sleep
disorders such as Advanced Sleep Phase Syndrome (ASPS) [15].
Measurement of circadian period length is therefore a useful step
in assessing circadian clock function, either experimentally or
clinically.
Determination of the period of circadian behavior in sighted
subjects requires prolonged subject observation under controlled-
light laboratory conditions. In humans, these studies are expensive
and labor-intensive. In one protocol, subjects are kept for multiple
days under ‘constant routine’ conditions consisting of sustained
wakefulness or scheduled sleep episodes under continuous dim light
with constant posture and frequent isocaloric meals [16,17].
Alternatively, circadian period can be measured under constant
dim light for several weeks [18]. Finally, it can be measured under
‘forced desynchrony’ (FD) conditions where the sleep-wake cycle is
scheduled to day-lengths that are outside the range of entrainment
for the circadian pacemaker, conditions which force the clock to
exhibit its endogenous period. Since it is not ethically possible to
keep human subjects in constant routine protocols for prolonged
periods, FD protocols are thought to offer greater precision. [4]. A
further special case employs totally blind individuals, whose
circadian pacemaker cannot be entrained by the environmental
light-dark cycle. Although under certain circumstances these
individuals can become entrained to the 24-hour day via nonphotic
cues such as exercise, food, and activity [19,20], in other cases they
exhibit ‘non-24-hour’ rhythms in melatonin, cortisol or temperature
under both laboratory and real-world conditions that provide a
direct estimate of their physiological period [21].
Given the intensive experimental control required to assess
human physiological period, our laboratories have taken advan-
tage of the duplication of the molecular mechanism of the
circadian clock in most mammalian tissues to measure period
length in human fibroblasts. To do this, we infect cells with a
lentiviral reporter containing the luciferase gene under control of a
circadian promoter. Period length in infected cells can then be
measured via real-time bioluminescence [22]. In mice with
mutations in circadian clock genes, a qualitative correlation has
been observed between behavioral period measured by wheel
running activity and fibroblast period measured by lentiviral
reporter; and in humans, extreme early-type individuals had on
average shorter fibroblast periods than extreme late-types [13].
Although these correlations among mutant animals or extreme
chronotypes are promising, it remains unclear how well human
period length is predicted from measurements in peripheral tissues
in ordinary individuals, and whether these values correlate with
sleep-wake timing in vivo.
In this report, we have for the first time directly compared
estimates of human physiological circadian period with the period
measured in fibroblasts from the same subjects. We used three
different subject groups whose physiological period was estimated
via different protocols, and which showed different population
averages for physiological period. In each trial, the correlations
that we observed suggested that this easy cellular method could be
used as a biomarker for human clock properties.
Results
Human fibroblast circadian period in vitro correlates with
estimates of human physiological period measured in
vivo in normal individuals
As described in Methods, we recruited subjects that had
participated previously in one of five different studies of
physiological period in three countries (Basel, Switzerland;
Novosibirsk, Russia; and Guildford, United Kingdom). Four
protocols estimated physiological period of sighted subjects under
controlled laboratory conditions designed to minimize the effects
of environmental light, exercise, food, and sleep upon the workings
of the circadian oscillator. Physiological period was determined by
the timing of melatonin, a hormone produced at night in circadian
fashion and measurable in human saliva. A fifth study focused
upon totally blind individuals. For such people, free-running
physiological period has been shown previously to remain
independent of the solar day even in a home environment under
some circumstances [21]. Hence, subject period could be
measured at home over several weeks via the periodicity of the
melatonin metabolite 6-sulfatoxymelatonin excreted in urine.
From each subject, two skin biopsies were taken and fibroblasts
were cultivated from them. The circadian period length of these
fibroblasts was then measured via transduction of a lentiviral
circadian reporter and subsequent long-term bioluminescent
monitoring. Figure 1B shows a portion of data from fibroblasts
of the same subject whose physiological period is shown in
Figure 1A.
For all subjects, estimates of physiological in vivo period were
compared to fibroblast period measured via transduction of a
lentiviral circadian reporter and subsequent long-term biolumi-
nescent monitoring. The results from 9 subjects measured from
two studies in Basel are shown in Figure 2A. Results from a further
11 subjects participating in two studies in Novosibirsk are shown in
Figure 2B. Finally, results from 8 totally blind individuals
measured in Guildford are shown in Figure 2C. All data are
graphed together in Figure 2D. In all groups, positive correlations
were observed between fibroblast period and physiological period
measured in the same subjects, and Bland-Altman statistics among
all subjects show an absence of systematic error between
measurements in vitro and in vivo (Figure S1). Table 1 shows the
specific values and correlation coefficients obtained from each
subject population.
Blind individuals showed longer physiological period but
equivalent fibroblast period
Average physiological period lengths were significantly longer
for the blind subjects than for the sighted subjects (Figure 3A), as
reported previously [4,21]. Surprisingly, average fibroblast period
was the same for these three populations when measured under
identical conditions (Figure 3B). In other words, cellular fibroblast
periods were similar among the groups of subjects even though
physiological periods varied. Therefore, fibroblast measurements
succeeded in capturing inter-individual differences in period
among members of each group (whether they were blind or
sighted), but were insensitive to apparent differences between blind
and sighted individuals.
Discussion
The fundamental mechanism of the mammalian circadian clock
is cell-autonomous, and is based upon feedback loops of
transcription and translation that use identical components in
most cells of the body [23]. In fact, long-term recordings suggest
that the intrinsic clocks in peripheral cells like fibroblasts are
probably as robust as those in the ‘‘master clock’’ of the brain SCN
[24]. Probably because of these mechanistic similarities, our
laboratory has been able to show previously that clock properties
of fibroblasts taken from subjects of extreme chronotype (i.e.
‘‘larks’’ and ‘‘owls’’) generally correlate with the results of
questionnaires about subject daily behavior. Many of these
Period in Human Fibroblasts
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extreme subjects, however, showed normal fibroblast period
length. We ascribed their behavior to alterations in other clock
properties like amplitude [13].
Thus, it remains unclear to what degree the genetically encoded
period length of the human circadian clock, as reflected in
peripheral tissues like fibroblasts, controls daily behavior in normal
individuals whose period lengths vary relatively little. Herein, we
have rigorously examined this matter by comparing directly
circadian period length measured from human fibroblasts and that
estimated physiologically in the same individuals, under different
experimental conditions. In the five studies from three laboratories
that we have analyzed, we have observed good correlations
between period lengths of the circadian oscillator in vivo and in vitro,
even among individuals whose clock properties vary very little
(Figure 2).
In vivo, circadian period length under free-running conditions
has been shown previously to correlate well with circadian phase
under entrained conditions. This circadian phase is best reflected
in outputs of the circadian oscillator, such as sleep-wake timing
[9,14]. In retrospect, we were interested to know to what extent
fibroblast period could predict sleep-wake timing, but our studies
were not designed to test this hypothesis and in most cases the
rigorous routines of our subjects also controlled sleep-wake.
Nevertheless, for the six subjects participating in a constant
routine protocol in Basel, physiological circadian phase was
measured on the first night of in-patient study via dim-light
melatonin onset, and spontaneous wakeup time the next day by
EEG. By comparing these two times, we could estimate a ‘‘phase
angle’’ of sleep timing with respect to melatonin, which from
previous studies should correlate with period [14]. In our case, we
could directly compare this phase angle with subject circadian
period length measured both in vitro and in vivo. A trend was
observed between sleep timing and circadian period length in vivo
(Figure 4A) and in fibroblasts (Figure 4B), but limited subject
number prevented it from reaching significance. A larger study
would be needed to answer this question more rigorously.
Approximation of human circadian period by cellular assays
could present important advantages. The measurement of human
circadian period in vivo, either via constant routine or forced
desynchrony protocols, is expensive and labor-intensive. An in-vitro
measure of human circadian period, if validated in vivo, could
provide an attractive lower-budget alternative. Nevertheless, it
Figure 1. Determination of circadian period in vivo and in vitro. A. In vivo period length was obtained from salivary melatonin content profiles
of normal sighted subjects under a constant routine protocol for three consecutive cycles. Data from one representative subject (Start25) are shown.
Open circles, melatonin measurement values. B. From the same subject, fibroblast cultures were obtained from two separate biopsies and infected
with a lentiviral bioluminescent circadian reporter. After synchronization with dexamethasone, circadian oscillations in bioluminescence were
recorded from eight measures over five days. Three cycles of this oscillation are shown aligned with the physiological data of part A. Period
calculations for both panels were conducted by cosinor fitting, and the best-fit curve is shown in color, along with its period length and goodness of
fit R2.
doi:10.1371/journal.pone.0013376.g001
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should be noted that fibroblast period measures are not a direct
proxy for measures of physiological period: for some subjects,
considerable differences between the two were observed, and
physiological period differences between sighted and blind subjects
were absent entirely in fibroblasts.
While it is too soon to be able to draw firm conclusions, it is
possible that fibroblast period might prove more useful than
physiological period in certain applications. For example,
determination of period length in fibroblasts under carefully
controlled conditions might permit separation of genetic effects
upon basic clock mechanism from environmental influences
present in more complex physiological measurements. Such
influences are vividly illustrated by the measurement of sighted
and blind subjects included in the present paper. In ours and other
published studies of sighted subjects, various protocols have all
given period values close to 24 hours [4,6], whereas period length
measured in blind subjects at home are longer, and average
24.5 hours [21] (See also Figure 3A,B). This discrepancy is
unlikely to result from differences in methodology: recent data
illustrates that period assessments in field studies of blind
individuals are comparable to period assessment under forced
desynchrony in the same subjects (Hull et al., in press). In reverse,
two groups of sighted subjects in our study were measured in near
Figure 2. Relationship between physiological period length and fibroblast period length. A. In vitro period length was obtained from skin
fibroblasts from nine sighted human subjects of normal chronotype, and compared to physiological period in the same individuals measured in two
constant routine studies (Basel Start and Likri). The solid line shows the best-fit linear regression (1st polynomial order) represented by the data, and
the dashed lines represent 95% confidence intervals to the indicated regression line, with goodness-of-fit R2 shown at lower right. The overall p-value
(vs. null-hypothesis slope of 0) is shown at upper-left. For this panel and also panels B and C, identical statistical measures are depicted. In addition,
the range and average for each group of subjects are shown in Table 1, and data for individual subjects are listed in Methods S1. B. The same
comparison was performed for 11 sighted subjects whose physiological period was measured in controlled laboratory conditions in two studies
(Novosibirsk). C. A further comparison was performed for 8 totally blind subjects whose physiological period was measured at home (Guildford).
Fibroblasts from the asterisked subject showed abnormal clock properties in vitro at different temperatures and were excluded from statistical
analysis. D. The results of all five studies are graphed on the same axes: Yellow, Basel; Red, Novosibirsk; Blue, Guildford.
doi:10.1371/journal.pone.0013376.g002
Table 1. Period lengths obtained from subjects by
physiological measurements and from fibroblast molecular
analyses.
Subject location N t in vitro t in vitro r2
Basel 9 24.0060.33 24.7160.38 0.46
(23.60–24.50) (24.15–25.29)
Novosibirsk 11 24.0760.20 24.7760.42 0.68
(23.71–24.31) (24.10–25.45)
Guildford 8 24.5260.27 24.4660.48 0.66
(24.13–24.92) (23.80–25.23)
doi:10.1371/journal.pone.0013376.t001
Period in Human Fibroblasts
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total darkness (,0.2lux, Novosibirsk), and showed the same
shorter period of the sighted subjects that we estimated with
constant routine (Basel), or that others have estimated in forced-
desynchrony protocols [4].
If the difference is not due to methodology, a basic question
arises: are the shorter periods of sighted subjects ‘‘aftereffects’’ of
entrainment to light, or is there a fundamental genetic difference
between these groups? Our measurements suggest that it is unlikely
that this difference is genetic: average fibroblast period was the same
in all groups that we investigated, blind and sighted (Figure 3), but
still reflected accurately genetic differences causing short and long
physiological periods within each group. It is possible, of course, that
fibroblast clocks are sensitive to some types of genetic variation but
insensitive to others. Nevertheless, in our study we favor the
hypothesis that circadian properties between blind and sighted
groups differed for physiological reasons rather than genetic ones:
for example, human physiological period length might be modified
by prior light history and/or retinal function [25]. In support of this
idea, individuals recently entrained to a simulated Martian day
length showed a longer period length afterward [26].
It should be mentioned that the period of fibroblasts is not
invariant, either: their circadian clocks are temperature-over-
compensated [27,28]. Thus, whereas normal biochemical reac-
tions slow as temperature decreases, circadian clocks increase in
speed. As a result, period length measured from fibroblast cells in
vitro varies with the temperature at which the measurement is
conducted. Not surprisingly, the best correlations with period
length in vivo are seen at physiological temperatures. In addition,
measurements conducted at different temperatures are correlat-
ed, preserving inter-subject differences (Figure S2A). Interesting
exceptions exist, however. For example, one subject showed
almost perfect temperature compensation at multiple tempera-
tures, in stark contrast to the temperature overcompensation
seen in all other subjects (Figure S2B). This subject also showed a
significant difference between period in vivo and period in vitro
(asterisked subject in Figure 2C). Although the meaning of
this difference is uncertain, we suggest that inter-individual
genetic variations also exist in the (thus far unknown) loci
implicated in temperature compensation by the human circadian
oscillator.
In the extreme case, our experiments suggest that a mea-
surement of ‘‘true’’ circadian period emanating from the
Figure 3. Relationship between population averages of human
physiological period length and fibroblast period length. A. The
average in vivo period lengths obtained from both protocols with
sighted individuals were significantly different from that of blind
subjects (p,0.01, 0.05). B. Nevertheless, the fibroblast-derived values
were not significantly different among all three populations. (1-way
Anova). Data are presented as a standard boxplot, with bars showing
the smallest and largest observed values, and box dimensions and
midline reflecting lower quartile (Q1), median (Q2), and upper quartile
(Q3) values.
doi:10.1371/journal.pone.0013376.g003
Figure 4. Circadian period and wake timing. A. Period length
measured in fibroblasts is plotted against the circadian phase angle of
sleep, calculated as the difference between the measured time of dim-
light melatonin onset on the first day of the protocol and the time of
subject spontaneous waking that morning. This value could only be
determined in one of the five studies presented (Basel constant
routine). Linear regression and statistical analyses were as in Figure 2. B.
Period length in vivo is plotted versus the same sleep phase angle.
doi:10.1371/journal.pone.0013376.g004
Period in Human Fibroblasts
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suprachiasmatic nucleus may be unrealistic. Both in vivo and in
vitro, the observed period appears to be altered by environmental
factors. Fibroblast period can be altered by temperature, and
physiological period might be sensitive to prior light history and/
or retinal function. Nevertheless, measurement of fibroblast
period at precise physiological temperatures offers a reasonable
approximation of physiological period determined by more
rigorous measures. Both values, in spite of their variance, show
strong inter-individual differences independent of environment or
method, and will likely provide exciting clues to understand the
genetic basis of human daily behavior and its influence upon
health.
Methods
Ethical Permission
The study protocol, screening questionnaires, and consent forms
were approved by the relevant ethical committee (the Ethical
Committee of Basel, Switzerland; the Ethical committee of the
Institute of Internal Medicine, SB RAMS, Novosibirsk, Russia; the
University of Surrey Advisory Committee on Ethics; and the
Moorfields Eye Hospital Ethics Committee) and conform to the
Declaration of Helsinki. Informed consent was obtained from all
subjects.
Subject selection
Subjects for this study were individuals who have previously or
concurrently participated in chronobiological studies of the
authors in Basel, Novosibirsk, or Guildford, and were additionally
recruited to donate skin biopsies for this study. In two studies
(Basel, Novosibirsk), extreme chronotypes were specifically
excluded. Where noted, physiological measurements have been
reported previously in other contexts. In brief, study participants
consisted of nine sighted subjects (6 men, 3 women, mean age 6
S.D. 48.3621.9 years) recruited in Basel, eleven sighted subjects (2
men, 9 women, mean age 6 S.D. 25.567.8 years) recruited in
Novosibirsk, and eight subjects with no perception of light (7 men,
1 woman, mean age 6 S.D. 54.667.4 years) recruited in
Guildford. Further information is cited in Methods S1.
Circadian period determination in vivo
In order to ensure that the correlations presented herein were
not dependent upon a particular method of determining circadian
period, each subject group described above participated in a
different protocol for the measurement of physiological period in
vivo. Detailed descriptions of each protocol are listed in Methods
S1. In brief, sighted subjects (Basel and Novosibirsk subject groups)
were required to adhere to a regular sleep-wake schedule for 5–14
days prior to admission to the laboratory. Subsequently, subjects
were maintained under various sets of ‘‘constant’’ conditions
designed to eliminate environmental influences upon the circadian
oscillator: a 60-hour multiple nap protocol or a 40-hour sleep
deprivation protocol (Basel) under constant dim-light (,8 lux)
conditions with constrained posture and frequent scheduled meals;
or a 4 to 9-day protocol under near-total darkness (,0.1 or 0.2
lux) with normal scheduled sleep episodes (Novosibirsk). Saliva
samples were collected at intervals of 0.3–3 hours and analysed for
melatonin content through a direct double-antibody radioimmu-
noassay (Bu¨hlmann Laboratories, Scho¨nenbuch, Switzerland).
Blind subjects (all with no perception of light, Guildford), were
studied in their own homes for 3–5 consecutive weeks. No attempt
was made to alter the lifestyles of the individuals during the study.
For such people, free-running physiological period has been shown
previously to remain independent of the solar day even in a home
environment [21]. For 48 hours each week, subjects collected
sequential ,4-hourly urine samples during the day plus an ,8-
hour overnight sample. Urinary 6-sulphatoxymelatonin (aMT6s)
concentrations were measured as described previously [29]. Period
lengths were determined by the timing of intervals between
melatonin rise, either by regression analysis in longer protocols
(Novosibirsk, Guildford), or by cosinor analysis for shorter ones
(Basel).
Measurement of fibroblast circadian period length
Subjects from each of the studies presented above were
recontacted to participate in the present investigation by donating
skin biopsies. The time elapsed between measurements in vivo and
fibroblast donation, as well as detailed protocols, are indicated in
Methods S1. Briefly, two cylindrical 2-mm diameter cutaneous
biopsies were taken from the buttocks or upper arms of each
subject. Fibroblasts were isolated from biopsies and infected using
Bmal1::luciferase lentivirus as described previously [22]. Five days
or more after human fibroblast infection, circadian rhythms were
synchronised by 100 nM dexamethasone (Sigma), and light output
was measured (3 measurements per biopsy; total of 6 measure-
ments per subject) in the presence of 0.1 nM luciferin in specially
built light-tight atmosphere-controlled boxes for at least 5 days.
Period determination was accomplished by cosinor analysis of data
between the second and the fifth day of measurement. Values are
presented as mean plus or minus standard error from four to eight
measurements.
Supporting Information
Figure S1 Bland-Altman statistics for period measurements. For
each subject, average period length (in vivo and in vitro) is plotted
against the difference between the two measurements, expressed in
standard deviations from the mean.
Found at: doi:10.1371/journal.pone.0013376.s001 (0.11 MB TIF)
Figure S2 Comparison of fibroblast period length measured at
36.5 degrees C and at 37.0 degrees C incubator temperature. A.
Period length was measured from skin fibroblasts of blind and
sighted subjects (from Guildford and Novosibirsk) at two different
incubator temperatures, and plotted in comparison. Most subjects
showed a similar augmentation in period at the higher
temperature (1.1+/20.3 hours). B. Extreme temperature com-
pensation properties in one subject; this individual (S45) is marked
with an asterisk in Figure 2. Fibroblast period lengths at 36.5, 37.0,
and 37.5 degrees C are shown for this subject (left) versus another
representative subject (S43) (right).
Found at: doi:10.1371/journal.pone.0013376.s002 (0.17 MB TIF)
Methods S1
Found at: doi:10.1371/journal.pone.0013376.s003 (0.16 MB
DOC)
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